Brief: Neuropace Receives FDA Guidance On Pma Supplement For Indication Expansion Into Idiopathic Generalized Epilepsy

NeuroPace

28/07/2026 23:32

July 28 (Reuters) - Neuropace Inc NPCE.O:
NEUROPACE RECEIVES FDA GUIDANCE ON PMA SUPPLEMENT FOR INDICATION EXPANSION INTO IDIOPATHIC GENERALIZED EPILEPSY
NEUROPACE - FDA REQUESTS ADDITIONAL CLINICAL EVIDENCE FROM NAUTILUS TRIAL FOR PMA SUPPLEMENT
NEUROPACE - TO SUBMIT SUBMISSION ISSUE REQUEST AND AMEND PMA SUPPLEMENT
NEUROPACE - RECEIVES FDA NOTICE PMA SUPPLEMENT FOR IGE NOT APPROVABLE IN CURRENT FORM
Source text: ID:nBw9K6FyGa
Further company coverage: NPCE.O

 ((((Reuters.Briefs@thomsonreuters.com;));))